Glycans in melanoma screening. Part 1. The role of β1,6-branched N-linked oligosaccharides in melanoma

Biochemical Society Transactions

Volumn 39, Issue 1, 2011, Pages 370-373

  Przybyło, Małgorzata ^a   Lityńska, Anna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

1,6 branched N linked oligosaccharide; Biomarker; Glycosylation; Melanoma; N acetylglucosaminyltransferase V

Indexed keywords

GLYCAN DERIVATIVE; OLIGOSACCHARIDE;

CANCER DIAGNOSIS; CANCER SCREENING; CONFERENCE PAPER; EARLY DIAGNOSIS; HUMAN; MALIGNANT TRANSFORMATION; MELANOMA; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN GLYCOSYLATION; RODENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EARLY DETECTION OF CANCER; GLYCOSYLATION; HUMANS; MELANOMA; OLIGOSACCHARIDES, BRANCHED-CHAIN; POLYSACCHARIDES; PROGNOSIS; SKIN NEOPLASMS;

RODENTIA;

EID: 79551499456     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390370     Document Type: Conference Paper

References (46)

1. Berwick, M. and Wiggins, C. (2006) The current epidemiology of cutaneous malignant melanoma. Front. Biosci. 11, 1244-1254
2. Chin, L., Garraway, L.A. and Fisher, D.E. (2006) Malignant melanoma: genetic and therapeutics in the genomic era. Genes Dev. 20, 2149-2182 (Pubitemid 44244518)
3. Markovic, S.N., Erickson, L.A., Rao, R.D., Weenig, R.H., Pockaj, B.A., Bardia, A., Vachon, C.M., Schild, S.E., McWilliams, R.R., Hand, J.L. et al. (2007) Malignant melanomain the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin. Proc. 82, 364-380
4. MacKie, R.M., Hauschild, A. and Eggermont, M.M. (2009) Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20 (Suppl. 6) vi1-vi7
5. Li, G. and Herlyn, M. (2000) Dynamics of intracellular communication during melanoma development. Mol. Med. Today 6, 163-169
6. Miller, A.J. and Mihm, Jr, M.C. (2006) Melanoma. N. Engl. J. Med. 355, 51-65
7. Balch, C.M., Soong, S., Gershenwald, J.E., Thompson, J.F., Reintgen, D.S., Cascinelli, N., Urist, M., McMasters, K.M., Ross, M.I., Kirkwood, J.M. et al. (2001) Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19, 3622-3634
8. Balch, C.M., Gershenwald, J.E., Soong, S., Thompson, J.F., Atkins, M.B., Byrd, D.R., Buzaid, A.C., Cochran, A.J., Coit, D.G., Ding, S. et al. (2009) Final Version of 2009 AJCC Melanoma Staging and Classification. J. Clin. Oncol. 27, 6199-6206
9. Markovic, S.N., Erickson, L.A., Rao, R.D., Weenig, R.H., Pockaj, B.A., Bardia, A., Vachon, C.M., Schild, S.E., McWilliams, R.R., Hand, J.L. et al. (2007) Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin. Proc. 82, 490-513
10. Hallberg, O. and Johansson, O. (2004) Malignant melanoma: not a sunshine story. Med. Sci. Monit. 10, 336-340
11. Diepgen, T.L. and Mahler, V. (2002) The epidemiology of skin cancer. Br. J. Dermatol. 146 (Suppl. 61) 1-6
12. Varki, A. (1993) Biological roles of oligosaccharides:all of the theories are correct. Glycobiology 3, 97-130
13. Gorelik, E., Galili, U. and Raz, A. (2001) On the role of cell surface carbohydrates and thier binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 20, 245-277 (Pubitemid 34595270)
14. Saxon, E. and Bertozzi, C.R. (2001) Chemical and biological strategies for engeneering cell surface glycosylation. Annu. Rev. Cell Dev. Biol. 17, 1-23
15. Lowe, J.B. and Marth, J.D. (2003) A genetic approach to mammalian glycan function. Ann. Rev. Biochem. 72, 643-691
16. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U.S.A. 99, 10231-10233
17. Kobata, A. and Amano, J. (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumors. Immunol. Cell. Biol. 83, 429-439
18. Zhao, J., Patwa, T.H., Lubman, D.M. and Simeone, D.M. (2008) Protein biomarkers in cancer: natural glycoprotein microarray approaches. Curr. Opin. Mol. Ther. 10, 602-610
19. Lau, K.S. and Dennis, J.W. (2008) N-glycans in cancer progression. Glycobiology 18, 750-760
20. Litynska, A., Przybylo, M., Hoja-Lukowicz, D., Pochec, E., Kremser, M., Ciolczyl-Wierzbicka, D., Łabȩdź, M. and Laidler, P. (2008) Protein glycosylation as marker of melanoma progression. Curr. Cancer Ther. Rev. 4, 144-148
21. Drake, P.M., Cho, W., Prakobphol, A., Johansen, E., Anderson, N.L., Regnier, F.E., Gbson, B.W. and Fisher, S.J. (2010) Sweeting the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236
22. Lityńska, A., Przybyło, M., Pochec, E., Hoja-Łukowicz, D., Ciołczyk, D., Laidler, P. and Gil, D. (2001) Comparison of the lectin-binding pattern in different melanoma cell lines. Melanoma Res. 11, 205-212 (Pubitemid 32578806)
23. Krengel, S., Groteluschen, F., Bartsch, S. and Tronnier, M. (2004) Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J. Cutan. Pathol. 31, 1-7
24. McGary, E.C., Lev, D.C. and Bar-Eli, M. (2002) Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol. Ther. 1, 459-465
25. Haass, N.K., Smalley, K.S.M., Li, L. and Herlyn, M. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 18, 150-159 (Pubitemid 40733333)
26. Dennis, J.W., Granovsky, M. and Warren, C.E. (1999) Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473, 21-34
27. Pawelek, J.M. (2007) Viewing malignant melanoma cells as macrophage tumor hybrids. Cell Adh. Migr. 1, 2-6
28. Pawelek, J.M. and Chakraborty, A.K. (2008) The cancer cell-leucocyte fusion theory of metastasis. Adv. Cancer Res. 101, 397-444
29. Litynska, A., Przybylo, M., Pochec, E., Kremser, E., Hoja-Lukowicz, D. and Sulowska, U. (2006) Does glycosylation of melanoma cells influence their interaction with fibronectin? Biochimie 88, 527-534
30. Ciołczyk-Wierzbicka, D., Amoresano, A., Casbarra, A., Hoja-Łukowicz, D., Lityńska, A. and Laidler, P. (2004) The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconj. J. 20, 483-492 (Pubitemid 43014142)
31. Granovsky, M., Fata, J., Pawling, J., Muller, W., Khokha, R. and Dennis, J.W. (2000) Supression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6, 306-312
32. Seberger, P.J. and Chaney, W.G. (1999) Control of Asn-linked, β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology 9, 235-241
33. Couldrey, C. and Green, J.E. (2000) Metastases: the glycan connection. Breast Cancer Res. 2, 321-323
34. Lazova, R. and Pawelek, J.M. (2009) Why do melanomas get so dark? Exp. Dermatol. 18, 934-938
35. Lazova, R., Klump, V. and Pawelek, J. (2009) Autophagy in cutaneous malignant melanoma. J. Cutan. Pathol. 37, 256-268
36. Ochwat, D., Hoja-Łukowicz, D. and Lityńska, A. (2004) N-glycoproteins bearing β1-6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spektrometry. Melanoma Res. 14, 479-485
37. Przybylo, M., Martuszewska, D., Pochec, E., Hoja-Lukowicz, D. and Litynska, A. (2007) Identification of proteins bering β1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis. Biochim. Biophys. Acta 1770, 1427-1435
38. Ciołczyk-Wierzbicka, D., Bodzioch, M., Gil, D., Zmudzińska, D., Dembińska-Kieć, A. and Laidler, P. (2007) Expression of fucosyltransferases contribute to invasive phenotype. Med. Chem. 3, 418-424
39. Laidler, P., Gil, D., Pituch-Noworolska, A., Ciołczyk, D., Ksia̧żek, D., Przybyło, M. and Lityńska, A. (2000) Expression of beta1 integrins and N-cadherin in bladder and melanoma cell lines. Acta Biochim. Pol. 47, 1159-1170
40. Hieken, T.J., Ronan, ,S.G., Farolan, M., Shilkaitis, A.L. and Das Gupta, T.K. (1999) Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer 15, 375-382
41. Vihinen, P., Nikkola, J., Vlaykova, ,T., Hahka-Kemppinen, M., Talve, L., Heino, J. and Pyrhönen, S. (2000) Prognostic value of β1 integrin expression in metastatic melanoma. Melanoma Res. 10, 243-251
42. Pocheć, E., Lityńska, A., Amoresano, A. and Casbarra, A. (2003) Glycosylation proflie of integrin α3β1 changes with melanoma progression. Biochim. Biophys. Acta 1643, 113-123
43. Gu, J. and Taniguchi, N. (2004) Regulation of integrin functions by N-glycans. Glycoconjugate J. 21, 9-15
44. Liu, Y., Pan, D., Bellis, S.L. and Song, Y (2008) Effect of altered glycosylation on the structure of the I-like domain of beta1 integrin: a molecular dynamics study. Proteins 73, 989-1000
45. Zhao, Y., Sato, Y., Isaji, T., Fukuda, T., Matsumoto, A., Miyoshi, E., Gu, J. and Taniguchi, N. (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275, 1939-1948
46. Gu, J., Isaji, T., Sato, Y., Kariya, Y. and Fukuda, T. (2009) Importance of N-glycosylation on alpha5beta1 integrin for its biological functions. Biol. Pharm. Bull. 32, 780-785